Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.86B |
| 2 |
Exxon Mobil
XOM
|
+$1.35B |
| 3 |
Apple
AAPL
|
+$1.19B |
| 4 |
NVIDIA
NVDA
|
+$1.18B |
| 5 |
Amazon
AMZN
|
+$1.06B |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.24B |
| 2 |
GE Aerospace
GE
|
+$712M |
| 3 |
Broadcom
AVGO
|
+$499M |
| 4 |
Apollo Global Management
APO
|
+$286M |
| 5 |
Super Micro Computer
SMCI
|
+$243M |
Sector Composition
| 1 | Technology | 31.9% |
| 2 | Financials | 12.27% |
| 3 | Healthcare | 11.66% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Communication Services | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Rigetti Computing
RGTI
$6.19B
| $3.21M | ﹤0.01% |
3,004,323
+1,732,787
| +136% | +$1.85M |
|
2952
Rigel Pharmaceuticals
RIGL
$681M
| $3.21M | ﹤0.01% |
390,782
+11,532
| +3% | +$94.8K |
|
2953
Generation Bio
GBIO
$39.9M
| $3.2M | ﹤0.01% |
113,591
+6,522
| +6% | +$184K |
|
|
ESSA
2954
DELISTED
ESSA Bancorp
ESSA
| $3.2M | ﹤0.01% |
181,663
+4,153
| +2% | +$73.1K |
|
2955
Global Water Resources
GWRS
$271M
| $3.19M | ﹤0.01% |
263,916
+12,247
| +5% | +$148K |
|
2956
Sera Prognostics
SERA
$118M
| $3.19M | ﹤0.01% |
538,868
+331,090
| +159% | +$1.96M |
|
|
HSHP
2957
Himalaya Shipping
HSHP
$396M
| $3.17M | ﹤0.01% |
346,354
+7,310
| +2% | +$67K |
|
2958
Monte Rosa Therapeutics
GLUE
$297M
| $3.17M | ﹤0.01% |
847,442
+111,909
| +15% | +$419K |
|
2959
Hamilton Beach Brands
HBB
$196M
| $3.16M | ﹤0.01% |
183,576
+106,781
| +139% | +$1.84M |
|
2960
Li Auto
LI
$24.8B
| $3.16M | ﹤0.01% |
176,467
+123
| +0.1% | +$2.2K |
|
2961
TORM
TRMD
$2.21B
| $3.15M | ﹤0.01% |
81,121
+616
| +0.8% | +$23.9K |
|
|
ONIT
2962
Onity Group Inc.
ONIT
$367M
| $3.13M | ﹤0.01% |
130,455
+5,058
| +4% | +$121K |
|
2963
Adverum Biotechnologies
ADVM
$63.4M
| $3.13M | ﹤0.01% |
455,787
+262,271
| +136% | +$1.8M |
|
2964
Medallion Financial
MFIN
$244M
| $3.13M | ﹤0.01% |
407,107
+231,048
| +131% | +$1.77M |
|
2965
Caribou Biosciences
CRBU
$168M
| $3.13M | ﹤0.01% |
1,905,661
+63,478
| +3% | +$104K |
|
2966
Biglari Holdings Class B
BH
$943M
| $3.12M | ﹤0.01% |
16,123
+490
| +3% | +$94.8K |
|
2967
Gyre Therapeutics
GYRE
$711M
| $3.1M | ﹤0.01% |
259,807
+99,218
| +62% | +$1.18M |
|
2968
Puma Biotechnology
PBYI
$225M
| $3.1M | ﹤0.01% |
950,146
+497,175
| +110% | +$1.62M |
|
|
NAGE
2969
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $3.09M | ﹤0.01% |
1,131,629
+570,570
| +102% | +$1.56M |
|
2970
Merus
MRUS
$5.26B
| $3.09M | ﹤0.01% |
52,186
-5,272
| -9% | -$312K |
|
2971
ThredUp
TDUP
$1.28B
| $3.09M | ﹤0.01% |
1,814,960
+147,694
| +9% | +$251K |
|
2972
Quest Resource Holding
QRHC
$34M
| $3.07M | ﹤0.01% |
348,939
+207,375
| +146% | +$1.83M |
|
2973
Capricor Therapeutics
CAPR
$291M
| $3.06M | ﹤0.01% |
641,573
+313,096
| +95% | +$1.49M |
|
2974
Flexsteel Industries
FLXS
$258M
| $3.06M | ﹤0.01% |
98,449
+55,333
| +128% | +$1.72M |
|
2975
Foghorn Therapeutics
FHTX
$293M
| $3.05M | ﹤0.01% |
531,110
+82,699
| +18% | +$476K |
|